How many institutions held MAZE - Maze Therapeutics, Inc. - Common Stock, $0.001 par value per share in Q3 2026?

3 institutional investors reported MAZE - Maze Therapeutics, Inc. - Common Stock, $0.001 par value per share for Q3 2026. Use the holders table for investor-level position and value details.

Maze Therapeutics, Inc. - Common Stock, $0.001 par value per share (MAZE)

Q: What does CUSIP 578784100 represent in this 13F holders report?

CUSIP 578784100 is the security identifier for MAZE - Maze Therapeutics, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 578784100

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / Common Stock, $0.001 par value per share
Total 13F shares: 687
Total 13F value: $18,672
Share change: +191
SEC-reported price per share: $27.18
Number of holders: 3
Value change: +$5,191
Number of buys: 2
Number of sells: 1
Shares outstanding: 55,150,259

Security key

578784100

Report period

Q3 2026

Institutions

Top holders

MAZE full security history Ownership snapshot Full 13F holder table Maze Therapeutics, Inc. SEC filings Maze Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 578784100

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of MAZE - Maze Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARCH Venture Fund X, L.P.

Disclosed value leader

Third Rock Ventures IV, L.P.

Comparable rows

15/15

Latest evidence

30 Jun 2026

13D/G 3/4/5 13F Lead comparable stake: 9.4% 13D/G row: ARCH Venture Fund X, L.P. Showing 1-6 of 15 holder rows.

Quick read

ARCH Venture Fund X, L.P. leads the comparable SEC ownership view at 9.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARCH Venture Fund X, L.P.'s linked filing trail.

Comparable ownership Top 5

ARCH Venture Fund X, L.P. 9.4%

Third Rock Ventures IV, L.P. 9.3%

Deep Track Capital, LP 9%

Frazier Life Sciences Public Fund... 9%

Janus Henderson Group Ltd. 5.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARCH Venture Fund X, L.P.	13D/G 13D/G	9.4%	$36,215,266 4,120,053 shares	$0	31 Mar 2025
Third Rock Ventures IV, L.P.	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	9.3%	$179,808,372 4,473,958 shares	-$64,304,000	31 Dec 2025
Deep Track Capital, LP	13F 13D/G Company 13F 13D/G	9% from 13D/G	$111,379,859 3,732,569 shares	—	30 Jun 2026
Frazier Life Sciences Public Fund, L.P.	13D/G 13D/G	9%	$174,515,671 4,342,266 shares	+$39,762,017	31 Dec 2025
Janus Henderson Group Ltd.	13D/G JANUS HENDERSON GROUP PLC 13D/G	5.8%	$78,390,380 2,858,876 shares	-$9,531,082	31 Mar 2026
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	5.4% from 13D/G	$104,524,775 3,502,841 shares	—	30 Jun 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

687

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders

160

Q3 2026 holders

Holder diff

-157

Investor	Q2 2026 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend